Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease.

Bangalore S, Pursnani S, Kumar S, Bagos PG.

Circulation. 2013 Feb 19;127(7):769-81. doi: 10.1161/CIRCULATIONAHA.112.131961. Epub 2013 Jan 16.

PMID:
23325526
[PubMed - indexed for MEDLINE]
Free Article
2.

Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.

Pursnani S, Korley F, Gopaul R, Kanade P, Chandra N, Shaw RE, Bangalore S.

Circ Cardiovasc Interv. 2012 Aug 1;5(4):476-90. doi: 10.1161/CIRCINTERVENTIONS.112.970954. Epub 2012 Aug 7. Review.

PMID:
22872053
[PubMed - indexed for MEDLINE]
Free Article
3.

Treatment Strategies for Women With Coronary Artery Disease [Internet].

Dolor RJ, Melloni C, Chatterjee R, Allen LaPointe NM, Williams JB, Coeytaux RR, McBroom AJ, Musty MD, Wing L, Samsa GP, Patel MR.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Aug.

PMID:
23016160
[PubMed]
Books & Documents
4.

Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.

Leonardi S, Thomas L, Neely ML, Tricoci P, Lopes RD, White HD, Armstrong PW, Giugliano RP, Antman EM, Califf RM, Newby LK, Mahaffey KW.

J Am Coll Cardiol. 2012 Dec 4;60(22):2296-304. doi: 10.1016/j.jacc.2012.09.005. Epub 2012 Nov 1.

PMID:
23122801
[PubMed - indexed for MEDLINE]
Free Article
5.

Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.

Morrow DA, Wiviott SD, White HD, Nicolau JC, Bramucci E, Murphy SA, Bonaca MP, Ruff CT, Scirica BM, McCabe CH, Antman EM, Braunwald E.

Circulation. 2009 Jun 2;119(21):2758-64. doi: 10.1161/CIRCULATIONAHA.108.833665. Epub 2009 May 18.

PMID:
19451347
[PubMed - indexed for MEDLINE]
Free Article
6.

Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials.

Stergiopoulos K, Brown DL.

Arch Intern Med. 2012 Feb 27;172(4):312-9. doi: 10.1001/archinternmed.2011.1484.

PMID:
22371919
[PubMed - indexed for MEDLINE]
7.

Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.

Al Suwaidi J, Holmes DR Jr, Salam AM, Lennon R, Berger PB.

Am Heart J. 2004 May;147(5):815-22.

PMID:
15131536
[PubMed - indexed for MEDLINE]
8.

Prognostic implications of procedural vs spontaneous myocardial infarction: results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry.

Bangalore S, Pencina MJ, Kleiman NS, Cohen DJ.

Am Heart J. 2013 Dec;166(6):1027-34. doi: 10.1016/j.ahj.2013.09.008. Epub 2013 Oct 14.

PMID:
24268217
[PubMed - indexed for MEDLINE]
9.

Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention.

Perera D, Stables R, Clayton T, De Silva K, Lumley M, Clack L, Thomas M, Redwood S; BCIS-1 Investigators.

Circulation. 2013 Jan 15;127(2):207-12. doi: 10.1161/CIRCULATIONAHA.112.132209. Epub 2012 Dec 6.

PMID:
23224207
[PubMed - indexed for MEDLINE]
Free Article
10.

A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris.

Thomas S, Gokhale R, Boden WE, Devereaux PJ.

Can J Cardiol. 2013 Apr;29(4):472-82. doi: 10.1016/j.cjca.2012.07.010. Epub 2012 Sep 23. Review.

PMID:
23010084
[PubMed - indexed for MEDLINE]
11.

Optimal medical therapy with or without PCI for stable coronary disease.

Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; COURAGE Trial Research Group.

N Engl J Med. 2007 Apr 12;356(15):1503-16. Epub 2007 Mar 26.

PMID:
17387127
[PubMed - indexed for MEDLINE]
Free Article
12.

Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).

Boden WE, O'Rourke RA, Teo KK, Maron DJ, Hartigan PM, Sedlis SP, Dada M, Labedi M, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS; COURAGE Trial Investigators.

Am J Cardiol. 2009 Jul 1;104(1):1-4. doi: 10.1016/j.amjcard.2009.02.059. Epub 2009 Apr 16.

PMID:
19576311
[PubMed - indexed for MEDLINE]
13.

Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials.

Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, Caixeta A, Feit F, Manoukian SV, White H, Bertrand M, Ohman EM, Parise H, Lansky AJ, Lincoff AM, Stone GW.

JACC Cardiovasc Interv. 2011 Jun;4(6):654-64. doi: 10.1016/j.jcin.2011.02.011.

PMID:
21700252
[PubMed - indexed for MEDLINE]
Free Article
14.

Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE; COURAGE Investigators.

Circulation. 2008 Mar 11;117(10):1283-91. doi: 10.1161/CIRCULATIONAHA.107.743963. Epub 2008 Feb 11.

PMID:
18268144
[PubMed - indexed for MEDLINE]
Free Article
15.

Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.

Singh M, Shah T, Khosla K, Singh P, Molnar J, Khosla S, Arora R.

Ther Adv Cardiovasc Dis. 2012 Jun;6(3):101-14. doi: 10.1177/1753944712446670. Epub 2012 May 4. Review.

PMID:
22562999
[PubMed - indexed for MEDLINE]
16.

Effect of statins pretreatment on periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: a meta-analysis.

Zhang F, Dong L, Ge J.

Ann Med. 2010 Apr;42(3):171-7. doi: 10.3109/07853890903463976.

PMID:
20384433
[PubMed - indexed for MEDLINE]
17.

Effectiveness of percutaneous coronary intervention in patients with silent myocardial ischemia (post hoc analysis of the COURAGE trial).

Gosselin G, Teo KK, Tanguay JF, Gokhale R, Hartigan PM, Maron DJ, Gupta V, Mancini GB, Bates ER, Chaitman BR, Spertus JA, Kostuk WJ, Dada M, Sedlis SP, Berman DS, Shaw LJ, O'Rourke RA, Weintraub WS, Boden WE; COURAGE Trial Investigators.

Am J Cardiol. 2012 Apr 1;109(7):954-9. doi: 10.1016/j.amjcard.2011.11.023.

PMID:
22445578
[PubMed - indexed for MEDLINE]
18.

Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR).

Damman P, Wallentin L, Fox KA, Windhausen F, Hirsch A, Clayton T, Pocock SJ, Lagerqvist B, Tijssen JG, de Winter RJ.

Circulation. 2012 Jan 31;125(4):568-76. doi: 10.1161/CIRCULATIONAHA.111.061663. Epub 2011 Dec 23.

PMID:
22199015
[PubMed - indexed for MEDLINE]
Free Article
19.

Discontinuation of long-term clopidogrel therapy is associated with death and myocardial infarction after saphenous vein graft percutaneous coronary intervention.

Sachdeva A, Bavisetty S, Beckham G, Shen AY, Aharonian V, Mansukhani P, Stone GW, Leon M, Moses J, Moore N, Hyett R, Contreras R, Brar SS.

J Am Coll Cardiol. 2012 Dec 11;60(23):2357-63. doi: 10.1016/j.jacc.2012.09.014. Epub 2012 Nov 7.

PMID:
23141495
[PubMed - indexed for MEDLINE]
Free Article
20.

Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.

Prasad A, Gersh BJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Pocock SJ, McLaurin BT, Cox DA, Lansky AJ, Mehran R, Stone GW.

J Am Coll Cardiol. 2009 Jul 28;54(5):477-86. doi: 10.1016/j.jacc.2009.03.063.

PMID:
19628125
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk